Pan-RAF inhibitor exarafenib targets BRAF class II/III NSCLC and reveals ARAF-KSR1 resistance and combination strategies
Overview of attention for article published in Nature Communications, February 2026
Altmetric Badge
About this Attention Score
-
Good Attention Score compared to outputs of the same age (69th percentile)
-
Average Attention Score compared to outputs of the same age and source
Readers on
- mendeley
- 15 Mendeley